Atlas Trials

GMZ2-Aluminum Hydroxide Phase I, Tübingen

Clinical trial NCT00397449 · UNKNOWN

Trial details

NCT number
NCT00397449
Sponsor
European Vaccine Initiative
Status
UNKNOWN
Phase
Phase 1
Study type
INTERVENTIONAL
Malaria
Start date
2006-10-01
Enrollment
30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.